UPDATE 1-Valeant to sweeten bid for Afexa
September 26, 2011 at 08:15 AM EDT
Sept 25 (Reuters) - Valeant Pharmaceuticals International said on Monday it planned raise its takeover offer for Canadian cold and flu medicine maker Afexa Life Sciences to 85 Canadian cents a share, topping from Paladin Labs.
